Survival Analysis of Patients with Triple-Negative Breast Cancer: A Single-Center Experience
نویسندگان
چکیده
منابع مشابه
Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience
BACKGROUND Anthracycline- and taxane-based adjuvant chemotherapies are the most frequently used systemic treatments for women with triple negative breast cancer (TNBC). Adding platinum derivatives in the neo-adjuvant setting has been shown to not only improve the pCR rates, but also the 3 year DFS for TNBC patients; however, data on platinum derivatives in the adjuvant setting are limited. ME...
متن کاملClinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience
INTRODUCTION Triple-negative breast cancer (TNBC) lacks estrogen and progesterone receptors and does not overexpress HER2. It displays a distinct clinical behavior. This study aims to assess the clinical, molecular and prognostic characteristics of TNBC patients. PATIENTS/METHODS TNBC patients, referred to a tertiary medical center, 1/1/2000 - 31/12/2005, were included. Clinical, molecular an...
متن کاملtriple-negative breast cancer survival in iranian patients.
this study focused on triple-negative breast cancer (tnbc) that is characterized by the lack of expression of estrogen receptor (er), progesterone receptor (pr), and human epidermal growth factor receptor 2 (her-2). the primary goal of this study was to describe the relation between triple-negative receptor status and survival. this is the first study about triple-negative breast cancer in our ...
متن کاملOutcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.
PURPOSE Triple-negative breast cancers account for 15% of breast carcinomas and, when present as early-stage disease, they are associated with higher rates of recurrence and early distant metastasis risk when compared to hormone receptor positive and human epidermal growth factor receptor (HER-2) positive breast cancers. In this study we aimed to explore the basic clinicopathological characteri...
متن کاملTriple-negative breast cancer survival in Iranian patients.
This study focused on triple-negative breast cancer (TNBC) that is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). The primary goal of this study was to describe the relation between triple-negative receptor status and survival. This is the first study about triple-negative breast cancer in our ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Oncological Sciences
سال: 2022
ISSN: ['2452-3364']
DOI: https://doi.org/10.37047/jos.2022-89749